Is triggering receptor expressed on myeloid cell 1 (TREM-1) protein a new marker of serious infectious complications in colorectal surgery?: case-matched pilot study

被引:0
|
作者
Pisarska-Adamczyk, Magdalena [1 ]
Rzepa, Anna [2 ]
Kapusta, Maria [3 ]
Zawadzka, Karolina [4 ]
Kusnierz-Cabala, Beata [5 ]
Wysocki, Michal [6 ]
Malczak, Piotr [2 ]
Major, Piotr [2 ]
Zub-Pokrowiecka, Anna [2 ]
Wierdak, Mateusz [2 ]
Pedziwiatr, Michal [2 ]
机构
[1] Jagiellonian Univ Med Coll, Dept Med Educ, Krakow, Poland
[2] Jagiellonian Univ Med Coll, Dept Gen Surg 2, Jakubowskiego 2, PL-30688 Krakow, Poland
[3] Jagiellonian Univ Med Coll, Chair Clin Biochem, Dept Diagnost, Krakow, Poland
[4] Jagiellonian Univ Med Coll, Doctoral Sch Med & Hlth Sci, Krakow, Poland
[5] Jagiellonian Univ Med Coll, Fac Med, Chair Med Biochem, Krakow, Poland
[6] Ludwik Rydygier Mem Hosp Krakow, Dept Gen Surg & Surg Oncol, Krakow, Poland
关键词
TREM-1; Colorectal; Surgery; Infectious; Complications; C-REACTIVE PROTEIN; POSTOPERATIVE COMPLICATIONS; BACTERIAL-INFECTION; SERUM PROCALCITONIN; CANCER; SURVIVAL;
D O I
10.1007/s00423-023-03103-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose The purpose of the study was to evaluate the usefulness of the triggering receptor expressed on myeloid cell 1 (TREM-1) protein as a marker for serious infectious complications during laparoscopic colorectal surgery.Methods Sixty-four patients with colon or rectal cancer, who underwent an elective laparoscopic colorectal cancer surgery from November 2018 to February 2020, were included in the analysis. Blood samples of the TREM-1 protein testing were collected four times from each patient: before and on three following postoperative days (PODs). Patients were divided into two groups according to the presence of infectious complications. Subsequently, patients with infectious complications (group 1) were matched 1:1 with patients without complications (group 2). The case-matched analysis was done by selecting patients from the control group by age, ASA scale, cancer stage, and type of surgery.Results There was no significant difference in demographic and operative characteristics between the two groups. The median length of hospital stay was longer in group 1 than in group 2 (11 days vs. 5 days, p < 0.001). Preoperative measurements of TREM-1 protein did not differ between the two groups. There were no significant differences in the measurements on the first and third postoperative days. However, the median TREM-1 measurement was higher in group 1 on the second postoperative day (542 pg/ml vs. 399 pg/ml; p = 0.040). The difference was more apparent when only severe postoperative complications were considered. When compared to the group without any complications, the median TREM-1 level was significantly higher in the group with severe infection complications in POD 1, POD 2, and POD 3 (p < 0.05). The receiver operating characteristic (ROC) curve demonstrated that TREM-1 readings in POD 2 had a sensitivity of 83% and a specificity of 84% for the presence of severe infection complications at a value of 579.3 pg/ml (AUC 0.8, 95%CI 0.65-0.96).Conclusion TREM-1 measurements might become a helpful predictive marker in the early diagnosis of serious infectious complications in patients following laparoscopic colorectal surgery.
引用
收藏
页数:8
相关论文
共 40 条
  • [1] Is triggering receptor expressed on myeloid cell 1 (TREM-1) protein a new marker of serious infectious complications in colorectal surgery?: case-matched pilot study
    Magdalena Pisarska-Adamczyk
    Anna Rzepa
    Maria Kapusta
    Karolina Zawadzka
    Beata Kuśnierz-Cabala
    Michał Wysocki
    Piotr Małczak
    Piotr Major
    Anna Zub-Pokrowiecka
    Mateusz Wierdak
    Michał Pędziwiatr
    Langenbeck's Archives of Surgery, 408
  • [2] Triggering receptor expressed on myeloid cells-1 (TREM-1) inhibition in atherosclerosis
    Panagopoulos, Anastasios
    Samant, Saurabhi
    Bakhos, Jules Joel
    Liu, Martin
    Khan, Behram
    Makadia, Janaki
    Muhammad, Fayaz
    Kievit, Forrest M.
    Agrawal, Devendra K.
    Chatzizisis, Yiannis S.
    PHARMACOLOGY & THERAPEUTICS, 2022, 238
  • [3] Triggering receptor expressed on myeloid cells-1 (TREM-1) a new player in antiviral immunity?
    Roe, Kelsey
    Gibot, Sebastien
    Verma, Saguna
    FRONTIERS IN MICROBIOLOGY, 2014, 5
  • [4] Crystal structure of human triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.47 Å
    Kelker, MS
    Foss, TR
    Peti, W
    Teyton, L
    Kelly, JW
    Wüthrich, K
    Wilson, IA
    JOURNAL OF MOLECULAR BIOLOGY, 2004, 342 (04) : 1237 - 1248
  • [5] Crystal structure of mouse triggering receptor expressed on myeloid cells 1 (TREM-1) at 1.76 Å
    Kelker, MS
    Debler, EW
    Wilson, IA
    JOURNAL OF MOLECULAR BIOLOGY, 2004, 344 (05) : 1175 - 1181
  • [6] Triggering receptor expressed on myeloid cells-1 (TREM-1) as a therapeutic target in infectious and noninfectious disease: a critical review
    Dantas, Pedro Henrique dos Santos
    Matos, Amanda de Oliveira
    da Silva Filho, Ernandes
    Silva-Sales, Marcelle
    Sales-Campos, Helioswilton
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2020, 39 (04) : 188 - 202
  • [7] Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) Contributes to Bordetella pertussis Inflammatory Pathology
    Gallop, Danisha
    Scanlon, Karen M.
    Ardanuy, Jeremy
    Sigalov, Alexander B.
    Carbonetti, Nicholas H.
    Skerry, Ciaran
    INFECTION AND IMMUNITY, 2021, 89 (10)
  • [8] Expression and function of triggering receptor expressed on myeloid cells-1 (TREM-1) on canine neutrophils
    Li, Jingjing
    Birkenheuer, Adam J.
    Marr, Henry S.
    Levy, Michael G.
    Yoder, Jeffrey A.
    Nordone, Shila K.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2011, 35 (08) : 872 - 880
  • [9] Triggering receptor expressed on myeloid cells-1 (TREM-1) expression on gastric epithelium:: implication for a role of TREM-1 in Helicobacter pylori infection
    Schmausser, B.
    Endrich, S.
    Beier, D.
    Moran, A. P.
    Burek, C. J.
    Rosenwald, A.
    Rieckmann, P.
    Mueller-Hermelink, H. -K.
    Eck, M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 152 (01) : 88 - 94
  • [10] The role of triggering receptor expressed on myeloid cells-1 (TREM-1) in central nervous system diseases
    Chunyan Zhang
    Xugang Kan
    Baole Zhang
    Haibo Ni
    Jianfeng Shao
    Molecular Brain, 15